The presence of substandard and falsified (SF) medical product at a significant level has become one of the threat to public health in Indonesia. BPOM as National Regulatory Authority in Indonesia has developed and implemented a policies to prevent, detect and act towards SF medical product. Nevertheless, these policies implementation has not effective to eliminate the threat. This study aimed to explore the gap exists in the policy implementation and develop a strategy using collaborative stakeholder approach among government institution and non-government organization. The study analyzes fact and data gathered by using in-depth interviews qualitatively involving 7 participants from two different categories. As a result, there are two main factors: 1) A different perception amongst the participants and 2) An obstacles to the policy implementation. Participants from non-government organization agreed that to eradicate SF required stakeholder collaboration to overcome the challenges. Furthermore, this study proposed an SF task force nationally model to empower the stakeholder's capacity, especially civil society, by implementing the science-technology-society concept. Through this model, the task force can mobilize resources response to every SF medical problems.